These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21495224)
1. Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk? Fish JD J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):98-101. PubMed ID: 21495224 [TBL] [Abstract][Full Text] [Related]
2. Part 2: Ovarian failure in adolescent cancer survivors should be treated. Hershlag A; Rausch ME; Cohen M J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):101-3. PubMed ID: 21495226 [TBL] [Abstract][Full Text] [Related]
3. Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure. Mulder JE Med Pediatr Oncol; 1999 Jul; 33(1):46-52. PubMed ID: 10401497 [No Abstract] [Full Text] [Related]
4. Introduction: Should ovarian failure in survivors of childhood cancers be treated with hormonal therapy? Appelbaum H J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):98. PubMed ID: 21495223 [No Abstract] [Full Text] [Related]
5. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy. Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632 [TBL] [Abstract][Full Text] [Related]
6. Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy. Chen R; Zhou H; Zhang Y Gynecol Endocrinol; 2013 Mar; 29(3):216-8. PubMed ID: 23153077 [TBL] [Abstract][Full Text] [Related]
7. Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer. Gargus E; Deans R; Anazodo A; Woodruff TK J Natl Compr Canc Netw; 2018 Sep; 16(9):1137-1149. PubMed ID: 30181423 [TBL] [Abstract][Full Text] [Related]
8. Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical? Garrido Oyarzún MF; Castelo-Branco C Gynecol Endocrinol; 2017 Jan; 33(1):10-15. PubMed ID: 27898259 [TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors. Blumenfeld Z; Zur H; Dann EJ Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871 [TBL] [Abstract][Full Text] [Related]
10. Sex hormone replacement in ovarian failure - new treatment concepts. Sassarini J; Lumsden MA; Critchley HO Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):105-14. PubMed ID: 25617176 [TBL] [Abstract][Full Text] [Related]
11. Two successful pregnancies in a patient with chemotherapy-induced ovarian failure while on hormone replacement therapy. Ghazeeri G; Awwad J Gynecol Endocrinol; 2012 Apr; 28(4):286-7. PubMed ID: 22122545 [TBL] [Abstract][Full Text] [Related]
12. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort. Chemaitilly W; Li Z; Krasin MJ; Brooke RJ; Wilson CL; Green DM; Klosky JL; Barnes N; Clark KL; Farr JB; Fernandez-Pineda I; Bishop MW; Metzger M; Pui CH; Kaste SC; Ness KK; Srivastava DK; Robison LL; Hudson MM; Yasui Y; Sklar CA J Clin Endocrinol Metab; 2017 Jul; 102(7):2242-2250. PubMed ID: 28368472 [TBL] [Abstract][Full Text] [Related]
13. Measuring ovarian function in young cancer survivors. Su HI Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920 [TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Sullivan SD; Sarrel PM; Nelson LM Fertil Steril; 2016 Dec; 106(7):1588-1599. PubMed ID: 27912889 [TBL] [Abstract][Full Text] [Related]
15. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. Larsen EC; Müller J; Schmiegelow K; Rechnitzer C; Andersen AN J Clin Endocrinol Metab; 2003 Nov; 88(11):5307-14. PubMed ID: 14602766 [TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen. Li Y; Xiao B; Xiao L; Zhang N; Yang H Intern Med; 2010; 49(6):611-3. PubMed ID: 20228602 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model. Melekoglu R; Ciftci O; Eraslan S; Cetin A; Basak N J Ovarian Res; 2018 Apr; 11(1):33. PubMed ID: 29699594 [TBL] [Abstract][Full Text] [Related]
18. What is the best management strategy for a 20-year-old woman with premature ovarian failure? Davies MC; Cartwright B Clin Endocrinol (Oxf); 2012 Aug; 77(2):182-6. PubMed ID: 22587818 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy in a patient with premature ovarian failure. Warenik-Szymankiewicz A; Słopień R Clin Exp Obstet Gynecol; 2014; 41(3):341-2. PubMed ID: 24992790 [TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels. Stangel-Wojcikiewicz K; Zdebik A; Jach R; Huras H; Wadowska-Jaszczynska K; Radon-Pokracka M; Kempisty-Zdebik E; Ludwin A; Ludwin I Neuro Endocrinol Lett; 2012; 33(7):697-702. PubMed ID: 23391877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]